Abstract
Amyloid-beta peptide is central to the pathology of Alzheimer's disease, because it is neurotoxic—directly by inducing oxidant stress, and indirectly by activating microglia. A specific cell-surface acceptor site that could focus its effects on target cells has been postulated but not identified. Here we present evidence that the 'receptor for advanced glycation end products' (RAGE) is such a receptor, and that it mediates effects of the peptide on neurons and microglia. Increased expression of RAGE in Alzheimer's disease brain indicates that it is relevant to the pathogenesis of neuronal dysfunction and death.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Goedert, M. Trends Neurosci. 16, 460–465 (1993).
Haass, C. & Selkoe, D. Cell 7, 1039–1042 (1994).
Kosik, K. J. Cell. Biol. 127, 1501–1504 (1994).
Trojanowski, J. & Lee, V. Am. J. Pathol. 144, 449–453 (1994).
Koo, E., Park, L. & Selkoe, D. Proc. Natl Acad. Sci. USA 90, 4748–4752 (1993).
Yanker, B., Duffy, L. & Kirschner, D. Science 250, 279–282 (1990).
Davis, J., McMurray, H. & Schubert, D. Biochem. Biophys. Res. Commun. 189, 1096–1100 (1992).
Pike, C. et al. Neuroscience 13, 1676–1687 (1993).
Hensley, K. et al. Proc. Natl Acad. Sci. USA 91, 3270–3274 (1994).
Behl, C., Davis, J., Lesley, R. & Schubert, D. Cell 77, 817–827 (1994).
Meda, L. et al. Nature 374, 647–650 (1995).
Klegeris, A., Walker, D. & McGeer, P. Biochem. Biophys. Res. Commun. 199, 984–991 (1994).
Araujo, D. & Cotman, C. Brain Res. 569, 141–145 (1992).
Joslin, G. et al. J. Biol. Chem. 266, 21897–21902 (1991).
Fraser, P. et al. J. Neurochem. 61, 298–305 (1993).
Ghiso, J. et al. Biochem. J. 293, 27–30 (1993).
Kimura, H. & Schubert, D. Proc. Natl Acad. Sci. USA 90, 7508–7512 (1993).
Strittmatter, W. et al. Proc. Natl Acad. Sci. USA 90, 1977–1981 (1993).
Strittmatter, W. et al. Exp. Neurol. 122, 327–334 (1993).
Schwarzman, A. Proc. Natl Acad. Sci. USA 91, 8368–8372 (1994).
Kisilevsky, R. et al. Nature Med. 1, 143–148 (1995).
Schmidt, A-M. et al. J. Biol. Chem. 267, 14987–14997 (1992).
Neeper, M. et al. J. Biol. Chem. 267, 14998–15004 (1992).
Hori, O. et al. J. Biol. Chem. 270, 25752–25761 (1995).
Rauvala, H. & Pihlaskari, R. J. Biol. Chem. 262, 16625–16635 (1987).
Yan, S-D. et al. Proc. Natl Acad. Sci. USA 91, 7787–7791 (1994).
Yan, S-D. et al. Nature Med. 1, 693–699 (1995).
Harris, J. et al. Exp. Neurol. 131, 193–202 (1995).
Mattson, M. & Goodman, Y. Brain Res. 676, 219–224 (1995).
Thomas, T. et al. Nature 380, 168–171 (1996).
Osborn, L. et al. Cell 59, 1203–1211 (1989).
Roher, A. et al. J. Biol. Chem. 268, 3072–3083 (1993).
Schmidt, A-M. et al. J. Clin. Invest. 91, 2155–2168 (1993).
Bocchini, V. et al. J. Neurosci. Res. 31, 616–621 (1992).
Dickson, D. et al. Glia 7, 75–83 (1993).
McGeer, P. et al. Glia 7, 84–92 (1993).
Wautier, J-L. et al. J. Clin. Invest. 97, 238–243 (1996).
Schmidt, A-M. et al. J. Clin. Invest. 96, 1395–1403 (1995).
Yan et al. J. Biol. Chem. 269, 9889–9897 (1994).
Rogers, J. et al. Neurology 43, 1609–1611 (1993).
Breitner, J. et al. Neurology 44, 227–232 (1994).
Gumkowski, F. et al. Blood Vessels 24, 11–18 (1987).
Yavin, E. & Yavin, Z. J. Cell Biol. 62, 540–546 (1974).
Dennery, P., Kramer, C. & Alpert, S. Am. J. Respir. Cell Mol. Biol. 3, 137–144 (1990).
Brett, J. et al. Am. J. Pathol. 143, 1699–1712 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yan, S., Chen, X., Fu, J. et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685–691 (1996). https://doi.org/10.1038/382685a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/382685a0
- Springer Nature Limited
This article is cited by
-
The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases
Translational Neurodegeneration (2024)
-
Alzheimer’s genes in microglia: a risk worth investigating
Molecular Neurodegeneration (2023)
-
The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer’s disease pathology models
Journal of Neuroinflammation (2023)
-
Activation of immune signals during organ transplantation
Signal Transduction and Targeted Therapy (2023)
-
E4orf1 improves adipose tissue-specific metabolic risk factors and indicators of cognition function in a mouse model of Alzheimer’s disease
Nutrition & Diabetes (2023)